Switzerland-based bioscience research tool manufacturer Biognosys closed a CHF2.7m ($3m) series A round on Monday last week with participation from backers including Syngenta Ventures, the corporate venturing unit for agribusiness company Syngenta.
Ignacio Martinez, a principal in Syngenta Ventures, has joined Biognosys’ board.
Joining Syngenta Ventures in the round were ZKB Startup Finance, the corporate venturing division of the Cantonal Bank of Zurich, venture capital fund Redalpine Capital and angel investor Hellmut Kirchner. Redalpine previously invested an undisclosed amount…
